Entera Bio Elects New Board Member and Approves Revised Compensation Terms at Annual Meeting
PorAinvest
domingo, 20 de julio de 2025, 3:11 am ET1 min de lectura
ENTX--
Additionally, shareholders ratified and approved revised compensation terms and a one-time grant of compensation for Chief Executive Officer and Director Miranda Toledano, with 19,524,783 votes for, 428,993 against, 542,191 abstentions, and 6,197,026 broker non-votes. Similar compensation proposals were approved for Chief of Research & Development Dr. Gregory Burshtein and Chief Financial Officer Dana Yaacov-Garbeli. Shareholders also ratified the company’s amended and restated compensation policy for directors and officers, and on an advisory, non-binding basis, compensation of the company’s named executive officers was approved [1].
Furthermore, shareholders approved the appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the company’s independent auditors for the fiscal year ending December 31, 2025. The vote was 26,617,578 in favor, 59,966 against, and 15,449 abstentions [1].
The election of Haya Taitel to the Board of Directors is expected to positively impact the company's governance and financial oversight. Analysts rate ENTX as a Buy with a $10.00 price target.
References:
[1] https://www.investing.com/news/sec-filings/entera-bio-shareholders-approve-board-election-and-compensation-proposals-93CH-4142570
Entera Bio elected Haya Taitel to its Board of Directors at its annual meeting, approved revised executive compensation, and ratified Kesselman & Kesselman as auditors. The election of a new board member is expected to positively impact the company's governance and financial oversight. Analysts rate ENTX as a Buy with a $10.00 price target.
Entera Bio Ltd. (NASDAQ: ENTX) held its 2025 Annual Meeting of Shareholders on Wednesday, where shareholders voted on several key proposals. The meeting saw the election of Haya Taitel to the Board of Directors for a three-year term, with 17,288,920 votes in favor, 3,069,140 against, 137,907 abstentions, and 6,197,026 broker non-votes [1].Additionally, shareholders ratified and approved revised compensation terms and a one-time grant of compensation for Chief Executive Officer and Director Miranda Toledano, with 19,524,783 votes for, 428,993 against, 542,191 abstentions, and 6,197,026 broker non-votes. Similar compensation proposals were approved for Chief of Research & Development Dr. Gregory Burshtein and Chief Financial Officer Dana Yaacov-Garbeli. Shareholders also ratified the company’s amended and restated compensation policy for directors and officers, and on an advisory, non-binding basis, compensation of the company’s named executive officers was approved [1].
Furthermore, shareholders approved the appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the company’s independent auditors for the fiscal year ending December 31, 2025. The vote was 26,617,578 in favor, 59,966 against, and 15,449 abstentions [1].
The election of Haya Taitel to the Board of Directors is expected to positively impact the company's governance and financial oversight. Analysts rate ENTX as a Buy with a $10.00 price target.
References:
[1] https://www.investing.com/news/sec-filings/entera-bio-shareholders-approve-board-election-and-compensation-proposals-93CH-4142570
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
Comentarios
Aún no hay comentarios